LM
Larry Michael Mertz
Chief Technology Officer

Larry Michael Mertz insider trades: Accelerate Diagnostics (AXDX) stock buys and sales

Chief Technology Officer, Accelerate Diagnostics Last trade Apr 4, 2025 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Larry reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 4, 2025AXDX↓ Sell$990
May 20, 2024AXDX↓ Sell$318
Apr 9, 2024AXDX↓ Sell$12K
Apr 4, 2024AXDX↓ Sell$861
May 22, 2023AXDX↓ Sell$3K
Mar 2, 2023AXDX↓ Sell$16K
Aug 30, 2022AXDX↑ Buy$80K
Aug 22, 2022AXDX↑ Buy$70K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Larry Michael Mertz's insider trades

Larry Michael Mertz is Chief Technology Officer at Accelerate Diagnostics (AXDX). Since Aug 22, 2022, Larry has reported 2 open-market purchases worth $150K and 6 sales worth $33K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (6 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.